NEW YORK (GenomeWeb) – DiagnoCure announced this week that the proxy advisory firms Institutional Shareholder Services and Glass Lewis have recommended that DiagnoCure shareholders vote to approve the sale of its PCA3 assets to Hologic subsidiary Gen-Probe. The sale was first announced in December — Gen-Probe will pay approximately $4.7 million for the assets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.